7.74
전일 마감가:
$7.99
열려 있는:
$8.05
하루 거래량:
47,239
Relative Volume:
0.31
시가총액:
$256.41M
수익:
$56.13M
순이익/손실:
$-14.67M
주가수익비율:
-10.46
EPS:
-0.74
순현금흐름:
$-9.13M
1주 성능:
-7.19%
1개월 성능:
+0.13%
6개월 성능:
-9.25%
1년 성능:
+48.47%
Journey Medical Corp Stock (DERM) Company Profile
명칭
Journey Medical Corp
전화
480-434-6670
주소
9237 E VIA DE VENTURA BLVD., SUITE 105, SCOTTSDALE
Compare DERM vs TAK, ZTS, HLN, TEVA, UTHR
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
|
DERM
Journey Medical Corp
|
7.71 | 265.72M | 56.13M | -14.67M | -9.13M | -0.74 |
|
TAK
Takeda Pharmaceutical Co Adr
|
18.32 | 57.75B | 29.85B | 776.90M | 4.35B | 0.2408 |
|
ZTS
Zoetis Inc
|
127.90 | 56.70B | 9.40B | 2.65B | 2.24B | 5.935 |
|
HLN
Haleon Plc Adr
|
11.16 | 49.70B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
33.86 | 39.96B | 17.41B | 1.43B | 1.00B | 1.2182 |
|
UTHR
United Therapeutics Corp
|
477.16 | 20.49B | 3.13B | 1.27B | 1.12B | 26.39 |
Journey Medical Corp Stock (DERM) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-08-25 | 개시 | H.C. Wainwright | Buy |
| 2025-07-30 | 재개 | B. Riley Securities | Buy |
| 2024-08-22 | 개시 | Rodman & Renshaw | Buy |
| 2024-06-28 | 재개 | ROTH MKM | Buy |
| 2021-12-07 | 개시 | B. Riley Securities | Buy |
Journey Medical Corp 주식(DERM)의 최신 뉴스
Buyout Rumor: Can Journey Medical Corporation be recession proofJuly 2025 Chart Watch & High Accuracy Swing Trade Signals - baoquankhu1.vn
Insurer Seeks To Cap Coverage In $3M Medical Transport Row - Law360
Essex Investment Management Co. LLC Acquires 125,818 Shares of Journey Medical Corporation $DERM - MarketBeat
Tetracyclines Market is Poised to Garner Valuation of USD 5.63 Billion by 2035 | Astute Analytica - GlobeNewswire Inc.
Journey Medical Corporation (NASDAQ:DERM) Given Consensus Recommendation of "Hold" by Brokerages - MarketBeat
Journey Medical (NASDAQ:DERM) Shares Down 3.7%Here's What Happened - MarketBeat
Patient journey goes digital at Ewha Womans Seoul Hospital - Healthcare IT News
B.Riley reiterates Buy rating on Journey Medical stock, maintains $12 target By Investing.com - Investing.com South Africa
B.Riley reiterates Buy rating on Journey Medical stock, maintains $12 target - Investing.com
10 Best Travel Insurance Companies For 2026 - Forbes
Will Journey Medical Corporation benefit from geopolitical trendsPortfolio Update Summary & Growth Oriented Trading Recommendations - mfd.ru
Value Recap: Can Journey Medical Corporation reach all time highs this year - baoquankhu1.vn
Risk Analysis: Is DUKPRA impacted by rising ratesMarket Risk Report & Community Supported Trade Ideas - baoquankhu1.vn
CVS Health Corp.: How a Pharmacy Giant Is Rebooting Itself as a Healthcare Platform - AD HOC NEWS
Journey Medical Corp entered into sales agreement to offer and sell up to 3.75 million shares of common stock - marketscreener.com
Journey Medical Corp Entered Into Sales Agreement To Offer And Sell Up To 3.75 Million Shares Of Common Stock - TradingView
Published on: 2026-01-20 22:55:08 - baoquankhu1.vn
Does Autonomix Medical Inc meet Warren Buffetts criteriaJuly 2025 Summary & Detailed Earnings Play Alerts - baoquankhu1.vn
Published on: 2026-01-19 20:20:55 - baoquankhu1.vn
Journey Medical Corp: Small-Cap Dermatology Stock Walks a Tightrope Between Turnaround Hopes and Vol - AD HOC NEWS
Is Cerus Corporation being accumulated by smart money2025 Volume Leaders & High Accuracy Investment Signals - baoquankhu1.vn
Journey Medical Corporation (NASDAQ:DERM) Given Average Recommendation of "Hold" by Analysts - MarketBeat
Journey Medical Corporation (NASDAQ:DERM) Given Average Recommendation of “Hold” by Analysts - Defense World
Journey Medical Files $150 Million Mixed Shelf - marketscreener.com
Journey Medical (NASDAQ:DERM) Trading 3.4% HigherHere's What Happened - MarketBeat
WebMD Launches Embody -- A Whole-Self Health, Weight Loss, and Weight Management Platform - The AI Journal
Early ZYCUBO treatment cut death risk nearly 80% in children with Menkes - Stock Titan
CVS Health Corp.: How a Pharmacy Giant Is Re?Engineering the Front Door to U.S. Healthcare - AD HOC NEWS
Axillary Hyperhidrosis Market to Evolve Rapidly Over the Next Decade by 2034, DelveInsight Observes | Botanix Pharma, Sound Surgical Tech, Dr. August Wolff GmbH, Medy-Tox, Journey Medical Corp. - Barchart.com
Journey Medical (DERM) Publishes Positive Emrosi Phase 1 Microbiome Data - MSN
Will Journey Medical Corporation stock gain from government policiesJuly 2025 Retail & AI Enhanced Trading Signals - Улправда
Is Microbot Medical Inc. (CY9D) stock vulnerable to rate hikesWeekly Stock Report & Weekly High Return Opportunities - ulpravda.ru
Can Tenon Medical Inc. Equity Warrant stock hit record highs againJuly 2025 Retail & Weekly Hot Stock Watchlists - Улправда
Why Orthofix Medical Inc. (OM2) stock is upgraded to buyAnalyst Upgrade & Safe Capital Growth Tips - Улправда
IMG Opens Applications for 2026 Spring Semester 'Student Journey Scholarship' - Yahoo Finance
Best Medical Travel Insurance Companies of 2026 - U.S. News & World Report
9 Best Performing Micro Cap Stocks in 2025 - Insider Monkey
Trending At The PTAB: The Journey Of IPR Institution In 2025 - Law360
The Truth About Journey Medical Corp (DERM): Tiny Stock, Big Drama – Is It Worth the Hype? - AD HOC NEWS
Layoff Tracker: Nido Will Close Following Lead Candidate’s Disappointing Phase II Results - BioSpace
Fourteen new option listings on November 12th - MSN
Public companies account for 34% of Journey Medical Corporation's (NASDAQ:DERM) ownership, while institutions account for 33% - Yahoo Finance
Journey Medical Corporation (NASDAQ:DERM) Receives Average Recommendation of "Hold" from Analysts - MarketBeat
Earnings Beat: Why Profound Medical Corp stock attracts high net worth investorsMarket Trend Review & Risk Controlled Swing Trade Alerts - moha.gov.vn
Aug Weekly: Can Quipt Home Medical Corp. stock reach $100 price targetPortfolio Return Report & Reliable Entry Point Alerts - ulpravda.ru
Journey Medical (NASDAQ:DERM) Trading 2.1% Higher – What’s Next? - Defense World
How Orthofix Medical Inc. stock performs in interest rate cycles2025 Volatility Report & Accurate Entry and Exit Point Alerts - ulpravda.ru
Sheets Smith Investment Management Invests $946,000 in Journey Medical Corporation $DERM - MarketBeat
Is Journey Medical Corporation stock cheap at current valuationWeekly Trade Review & Target Return Focused Stock Picks - Улправда
Journey Medical (NASDAQ:DERM) Trading 2.1% HigherWhat's Next? - MarketBeat
How Journey Medical Corporation stock benefits from tech adoptionWeekly Investment Summary & Smart Allocation Stock Tips - Улправда
Journey Medical Corp (DERM) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):